Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

New data on prostate-cancer mortality after PSA screening.

Miller AB.

N Engl J Med. 2012 Mar 15;366(11):1047-8. doi: 10.1056/NEJMe1200185. No abstract available.

PMID:
22417259
2.

Prostate-cancer mortality after PSA screening.

Wolf AM.

N Engl J Med. 2012 Jun 7;366(23):2230; author reply 2231. doi: 10.1056/NEJMc1204298#SA4. No abstract available.

PMID:
22670917
3.

Prostate-cancer mortality after PSA screening.

Autier P, Boniol M, Perrin P.

N Engl J Med. 2012 Jun 7;366(23):2230; author reply 2230-1. doi: 10.1056/NEJMc1204298#SA3. No abstract available.

PMID:
22670916
4.

Prostate-cancer mortality after PSA screening.

D'Amico AV.

N Engl J Med. 2012 Jun 7;366(23):2229; author reply 2230-1. doi: 10.1056/NEJMc1204298#SA2. No abstract available.

PMID:
22670915
5.

Prostate-cancer mortality after PSA screening.

Djulbegovic M, Neuberger MM, Dahm P.

N Engl J Med. 2012 Jun 7;366(23):2228-9; author reply 2230-1. doi: 10.1056/NEJMc1204298#SA1. No abstract available.

PMID:
22670914
6.

Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium.

Djavan B.

Eur Urol. 2010 Jun;57(6):928-9. doi: 10.1016/j.eururo.2010.03.002. Epub 2010 Mar 9. No abstract available.

PMID:
20304552
7.

PSA at 60 may predict risk of death from prostate cancer.

Rees J.

Practitioner. 2010 Oct;254(1733):5. No abstract available.

PMID:
21141246
8.

Death knell for PSA screening?

Mani H.

Natl Med J India. 2011 Nov-Dec;24(6):380. No abstract available.

PMID:
22680272
9.

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.

Committee for Establishment of the Guidelines on Screening for Prostate Cancer; Japanese Urological Association.

Int J Urol. 2010 Oct;17(10):830-8. doi: 10.1111/j.1442-2042.2010.02613.x.

10.

Prostate-specific antigen testing and prostate cancer screening.

Djavan B, Eckersberger E, Finkelstein J, Sadri H, Taneja SS, Lepor H.

Prim Care. 2010 Sep;37(3):441-59, vii. doi: 10.1016/j.pop.2010.05.001. Review.

PMID:
20705192
11.

[Clinical value of prostate specific antigen screening in early detection of prostate cancer].

Hua LX, Qiao D, Song NH, Feng NH, Yang J, Zhang JX, Chen JG, Zhang W, Sui YG, Wu HF.

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):705-9. Chinese.

PMID:
20021870
12.

[Screening for prostate cancer: an up date].

Ito K.

Gan To Kagaku Ryoho. 2012 Jan;39(1):33-7. Japanese.

PMID:
22241351
13.
14.

Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

Vutuc C, Schernhammer ES, Haidinger G, Waldhör T.

Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61.

PMID:
16091872
15.

Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening.

D'Amico AV, Whittington R, Malkowicz SB, Renshaw AA, Tomaszewski JE, Bentley C, Schultz D, Rocha S, Wein A, Richie JP.

Urology. 2001 Sep;58(3):406-10.

PMID:
11549489
16.

Prostate-specific antigen screening and mortality from prostate cancer.

Marcella SW, Rhoads GG, Carson JL, Merlino F, Wilcox H.

J Gen Intern Med. 2008 Mar;23(3):248-53. doi: 10.1007/s11606-007-0479-7. Epub 2008 Jan 3.

17.

Prostate cancer: screening and early detection.

Cookson MM.

Cancer Control. 2001 Mar-Apr;8(2):133-40. Review.

PMID:
11326167
18.

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.

Bangma CH, van Schaik RH, Blijenberg BG, Roobol MJ, Lilja H, Stenman UH.

Eur J Cancer. 2010 Nov;46(17):3109-19. doi: 10.1016/j.ejca.2010.09.031.

PMID:
21047594
19.

False-positive screening results in the Finnish prostate cancer screening trial.

Kilpeläinen TP, Tammela TL, Määttänen L, Kujala P, Stenman UH, Ala-Opas M, Murtola TJ, Auvinen A.

Br J Cancer. 2010 Feb 2;102(3):469-74. doi: 10.1038/sj.bjc.6605512. Epub 2010 Jan 5.

20.

Prostate-specific antigen: an evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer.

Payne H, Cornford P.

Urol Oncol. 2011 Nov-Dec;29(6):593-601. doi: 10.1016/j.urolonc.2009.11.003. Epub 2010 Jan 8. Review.

PMID:
20060331

Supplemental Content

Support Center